| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 56796 |
| 1 | ADALIMUMAB | 47375 |
| 2 | DUPILUMAB | 36707 |
| 3 | METHOTREXATE SODIUM | 14294 |
| 4 | METHOTREXATE | 14128 |
| 5 | TIRZEPATIDE | 13906 |
| 6 | EVOLOCUMAB | 10927 |
| 7 | DULAGLUTIDE | 9956 |
| 8 | GALCANEZUMAB-GNLM | 7524 |
| 9 | PREDNISONE | 7354 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE INJECTION | 128 | 0.6667 |
| 1 | SOMATROGON-GHLA | 789 | 0.6515 |
| 2 | MOTIXAFORTIDE | 37 | 0.3737 |
| 3 | LENACAPAVIR SODIUM | 137 | 0.2965 |
| 4 | GALCANEZUMAB-GNLM | 7524 | 0.2403 |
| 5 | GLATIRAMER ACETATE INJECTION | 715 | 0.1539 |
| 6 | OCRELIZUMAB AND HYALURONIDASE | 59 | 0.1464 |
| 7 | SIBEPRENLIMAB | 42 | 0.1391 |
| 8 | ASFOTASE ALFA | 1327 | 0.1332 |
| 9 | ZILUCOPLAN | 95 | 0.1163 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 60798 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 36707 |
| 2 | GLP-1 Receptor Agonist [EPC] | 27665 |
| 3 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 13906 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 13838 |
| 5 | PCSK9 Inhibitor [EPC] | 12186 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11979 |
| 7 | Corticosteroid [EPC] | 11711 |
| 8 | Insulin Analog [EPC] | 10555 |
| 9 | Vitamin C [EPC] | 8789 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1327 | 0.1332 |
| 1 | Recombinant Human Growth Hormone [EPC] | 1874 | 0.0856 |
| 2 | Cytolytic Agent [EPC] | 191 | 0.0822 |
| 3 | Melanocortin 4 Receptor Agonist [EPC] | 22 | 0.0815 |
| 4 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 3 | 0.0811 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 36707 | 0.0766 |
| 6 | APOC-III-directed RNA Interaction [EPC] | 4 | 0.0714 |
| 7 | Interleukin-13 Antagonist [EPC] | 562 | 0.0709 |
| 8 | PCSK9 Inhibitor [EPC] | 12186 | 0.0659 |
| 9 | GLP-1 Receptor Agonist [EPC] | 27665 | 0.0657 |